☆ 4.5 Article

New Onset of Smell and Taste Loss Are Common Findings Also in Patients With Symptomatic COVID-19 After Complete Vaccination

LARYNGOSCOPE (2022)

Related references

Note: Only part of the references are listed.

Article Otorhinolaryngology

Prevalence of Persistent Olfactory Disorders in Patients With COVID-19: A Psychophysical Case-Control Study With 1-Year Follow-up

Luigi Angelo Vaira et al.

Summary: This study evaluated olfactory dysfunction in patients after COVID-19 and found that the prevalence of OD was significantly higher in the COVID-19 group compared to the control group, indicating that this result was not affected by the baseline prevalence of OD in the general population.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2022)

Add to Collection

Editorial Material Otorhinolaryngology

Analysis of the correlations between the severity of lung involvement and olfactory psychophysical scores in coronavirus disease 2019 (COVID-19) patients

Antonio Matteo Amadu et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2022)

Add to Collection

Article Otorhinolaryngology

Clinical, virological and immunological evolution of the olfactory and gustatory dysfunction in COVID-19

Eugenia Maiorano et al.

Summary: This study longitudinally monitored the clinical, virological, and serological features of new-onset OGD related to COVID-19, revealing that OGD severity was associated with hormonal disorders and RNA detectability in NS, but not with RNA levels or IgG titers.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Prevalence of Olfactory Dysfunction in Coronavirus Disease 2019 (COVID-19): A Meta-analysis of 27,492 Patients

Jeyasakthy Saniasiaya et al.

Summary: A systematic review and meta-analysis found that the overall prevalence of olfactory dysfunction in COVID-19 patients is 47.85%, with European patients having the highest prevalence and Asian patients the lowest. Discrepancies between objective and subjective evaluations suggest further studies are needed.

LARYNGOSCOPE (2021)

Add to Collection

Article Medicine, Research & Experimental

COVID-19: Recovery from Chemosensory Dysfunction. A Multicentre study on Smell and Taste

Andreas Steenholt Niklassen et al.

Summary: Chemosensory dysfunction is common in COVID-19, with significant differences in olfactory function during and after infection. Most patients recover within the first 28 days, but some may experience persistent dysfunction and should seek specialist care.

LARYNGOSCOPE (2021)

Add to Collection

Article Microbiology

Psychophysical Evaluation of the Olfactory Function: European Multicenter Study on 774 COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: Objective evaluation of olfactory function in COVID-19 patients is challenging due to logistical and safety issues. Psychophysical tests provide more accurate results than patient self-reports. Olfactory disturbances appear to be largely independent of epidemiological and clinical characteristics.

PATHOGENS (2021)

Add to Collection

Article Medicine, General & Internal

Clinical features of patients who had two COVID-19 episodes: a European multicentre case series

J. R. Lechien et al.

Summary: The study found that patients who had two COVID-19 infections had similar clinical features in the second episode as the first, with most patients experiencing milder symptoms in both episodes and shorter duration in the second episode. The occurrence of loss of smell was unpredictable between the first and second infections.

JOURNAL OF INTERNAL MEDICINE (2021)

Add to Collection

Article Otorhinolaryngology

Validity and reliability of the COVID-19 symptom index, an instrument evaluating severity of general and otolaryngological symptoms

Jerome R. Lechien et al.

Summary: A clinical instrument, the CSI, was developed to evaluate symptoms of COVID-19 patients, showing high internal consistency, validity, and responsiveness to change.

ACTA OTO-LARYNGOLOGICA (2021)

Add to Collection

Article Otorhinolaryngology

Six-month smell and taste recovery rates in coronavirus disease 2019 patients: a prospective psychophysical study

M. Petrocelli et al.

Summary: A study found that six months after the onset of COVID-19, about 6% of patients still had severe persistent olfactory or gustatory disturbances.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study

Jamie Lopez Bernal et al.

Summary: This study estimated the real-world effectiveness of Pfizer-BioNTech BNT162b2 and Oxford-AstraZeneca ChAdOx1-S vaccines against confirmed COVID-19 symptoms, hospital admissions, and deaths. The vaccines showed significant reduction in symptomatic COVID-19 among older adults and further protection against severe disease. Both vaccines demonstrated similar effects and protection was maintained for over 6 weeks.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Add to Collection

Article Otorhinolaryngology

Risk factors and characteristics associated with persistent smell loss in coronavirus disease 2019 (COVID-19) patients

Bita Shahrvini et al.

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2021)

Add to Collection

Article Behavioral Sciences

Chemosensory Dysfunctions Induced by COVID-19 Can Persist up to 7 Months: A Study of Over 700 Healthcare Workers

Nicholas Bussiere et al.

Summary: Studies have shown that some COVID-19 patients may experience chemosensory alterations or impairments. A research on 704 healthcare workers revealed that a significant proportion of infected individuals still have chemosensory impairments 3-7 months after their infection.

CHEMICAL SENSES (2021)

Add to Collection

Article Clinical Neurology

Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction

Sven Saussez et al.

Summary: No clinical markers were found to predict the evolution of olfactory dysfunction (OD) at 60 days. Patients with poor olfactory outcome at 60 days had lower levels of salivary and nasal antibodies, suggesting a role for local immune responses in the persistence of COVID-19 related OD.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Otorhinolaryngology

Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?

L. A. Vaira et al.

Summary: The study showed that D-dimer, procalcitonin, ferritin, and neutrophil-to-lymphocyte ratio were significantly correlated with severe COVID-19, while olfactory disturbances appeared to have little prognostic value in predicting disease severity. The lack of correlation between olfactory disturbances and inflammatory markers suggests that the underlying pathogenesis of smell loss in COVID-19 patients may be more related to local rather than systemic factors.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

Add to Collection

Article Medicine, Research & Experimental

Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients

Luigi Angelo Vaira et al.

Summary: This study aimed to evaluate the correlations between the severity and duration of olfactory dysfunctions in COVID-19 patients. The presence of OD does not seem to be useful in identifying super-spreaders or predicting long-term OD development. Similarly, the pathogenesis of OD is probably related to individual factors rather than viral load.

LARYNGOSCOPE (2021)

Add to Collection

Article Medicine, General & Internal

Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines

Mark G. Thompson et al.

Summary: The study demonstrated that COVID-19 mRNA vaccines were highly effective in preventing SARS-CoV-2 infection in real-world conditions, while also attenuating the viral RNA load, febrile symptoms, and illness duration among vaccinated individuals who had breakthrough infections.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Anosmia and Ageusia: Common Findings in COVID-19 Patients

Luigi A. Vaira et al.

LARYNGOSCOPE (2020)

Add to Collection

Article Medicine, Research & Experimental

COVID-19 Viral Load in the Severity of and Recovery From Olfactory and Gustatory Dysfunction

Ryan H. W. Cho et al.

LARYNGOSCOPE (2020)

Add to Collection

© Peeref 2019-2024. All rights reserved.